Epsilon M&A Deal Report - Humco
Transaction Multiples for the Valuation of Private Companies
Fagron / Humco
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Biomedical Research Laboratory
EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
---|---|---|---|---|---|---|---|---|
Historic | ![]() |
![]() |
||||||
Current |
![]() |
Multiple available |
n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 129
- Number of EMAT Reports / sub-sector « Biomedical Research Laboratory » = 34
Date | Acquirer | Target | Country | Multiples | See details |
30/06/2016 | Richter Gedeon Vegyeszeti Gyar Nyrt | Finox Group | Switzerland | * | 90083 |
22/07/2016 | Private Group led by GSO Capital | Groupe Omega | Haute-Garonne | * | 89569 |
Source: Epsilon Research / EMAT